Apolipoprotein B-100 and ApoA-II kinetics as determinants of cellular cholesterol efflux

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 9, 2012, Pages

  Chan, Dick C ^a   Hoang, Anh ^c   Barrett, P Hugh R ^a,b   Wong, Annett T Y ^a   Nestel, Paul J ^c   Sviridov, Dmitri ^c   Watts, Gerald F ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A2; APOLIPOPROTEIN B100; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BODY MASS; CELL KINETICS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; COMMUNITY LIVING; CORRELATION ANALYSIS; ENZYME BLOOD LEVEL; EX VIVO STUDY; FRACTIONAL CATABOLIC RATE; HUMAN; HUMAN CELL; IN VIVO STUDY; INSULIN BLOOD LEVEL; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; PROTEIN METABOLISM; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; ANTHROPOMETRY; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; APOLIPOPROTEIN B-100; BLOOD CHEMICAL ANALYSIS; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; HUMANS; KINETICS; MALE; MIDDLE AGED; MODELS, STATISTICAL; REGRESSION ANALYSIS;

EID: 84866145899     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1522     Document Type: Article

References (31)

1. Lewis GF, Rader DJ 2005 New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96:1221-1232 (Pubitemid 40962099)
2. Rosenson RS, Brewer Jr HB, Davidson WS, Fayad ZA, Fuster V, Goldstein J, Hellerstein M, Jiang XC, Phillips MC, Rader DJ, Remaley AT, Rothblat GH, Tall AR, Yvan-Charvet L 2012 Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 125:1905-1919
3. Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL, Mohler ER, Rothblat GH, Rader DJ 2011 Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 364:127-135
4. Schwartz CC, VandenBroek JM, Cooper PS 2004 Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans. J Lipid Res 45:1594-1607 (Pubitemid 39296198)
5. Chan DC, Watts GF, Barrett PH, Mori TA, Belin LJ, Redgrave TG 2002 Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity. J Clin Endocrinol Metab 87:2283-2289 (Pubitemid 34521521)
6. Watts GF, Barrett PH, Ji J, Serone AP, Chan DC, Croft KD, Loehrer F, Johnson AG 2003 Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome. Diabetes 52:803-811 (Pubitemid 36323589)
7. Barrett PH, Chan DC, Watts GF 2006 Design and analysis of lipoprotein tracer kinetics studies in humans. J Lipid Res 47:1607-1619 (Pubitemid 44222813)
8. Gregersen MI, Rawson RA 1959 Blood volume. Physiol Rev 39:307-342
9. Nikkilä EA, Kekki M 1973 Plasma triglyceride transport kinetics in diabetes mellitus. Metab Clin Exp 22:1-22
10. Riches FM, Watts GF, Naoumova RP, Kelly JM, Croft KD, Thompson GR 1998 Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity. Int J Obes Relat Metab Disord 22:414-423 (Pubitemid 28211969)
11. Hoang A, Drew BG, Low H, Remaley AT, Nestel P, Kingwell BA, Sviridov D 2012 Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein. Eur Heart J 33:657-665
12. Sviridov D, Hoang A, Ooi E, Watts G, Barrett PH, Nestel P 2008 Indices of reverse cholesterol transport in subjects with metabolic syndrome after treatment with rosuvastatin. Atherosclerosis 197:732-739 (Pubitemid 351417870)
13. Beghin L, Duhal N, Poulain P, Hauw P, Lacroix B, Lecerf JM, Bonte JP, Fruchart JC, Luc G 2000 Measurement of apolipoprotein B concentration in plasma lipoproteins by combining selective precipitation and mass spectrometry. J Lipid Res 41:1172-1176 (Pubitemid 30483023)
14. deGoma EM, deGoma RL, Rader DJ 2008 Beyond high-density lipoprotein cholesterol levels: evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J Am Coll Cardiol 51:2199-2211 (Pubitemid 351754991)
15. Sviridov D, Mukhamedova N, Remaley AT, Chin-Dusting J, Nestel P 2008 Antiatherogenic functionality of high density lipoprotein: how much versus how good. J Atheroscler Thromb 15:52-62
16. Sviridov D, Nestel P 2002 Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis 161:245-254 (Pubitemid 34219176)
17. Lund-Katz S, Hammerschlag B, Phillips MC 1982 Kinetics and mechanism of free cholesterol exchange between human serum high- and low-density lipoproteins. Biochemistry 21:2964-2969 (Pubitemid 12067512)
18. Huang Y, von Eckardstein A, Assmann G 1993 Cell-derived unesterified cholesterol cycles between different HDLs and LDL for its effective esterification in plasma. Arterioscler Thromb 13:445-458 (Pubitemid 23075635)
19. Atger VM, de la Llera Moya M, Stoudt GW, Rodrigueza WV, Phillips MC, Rothblat GH 1997 Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells. J Clin Invest 99:773-780 (Pubitemid 27097681)
20. Chung BH, Franklin F, Cho BH, Segrest JP, Hart K, Darnell BE 1998 Potencies of lipoproteins in fasting and postprandial plasma to accept additional cholesterol molecules released from cell membranes. Arterioscler Thromb Vasc Biol 18:1217-1230 (Pubitemid 28376178)
21. Franceschini G, Calabresi L, Colombo C, Favari E, Bernini F, Sirtori CR 2007 Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patients. Atherosclerosis 195:385-391 (Pubitemid 350087947)
22. de Vries R, Groen AK, Perton FG, Dallinga-Thie GM, van Wijland, Dikkeschei LD, Wolffenbuttel BH, van Tol A, Dullaart RP 2008 Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre β-HDL, phospholipid transfer protein and cholesterol esterification. Atherosclerosis 196:733-741
23. Fournier N, Francone O, Rothblat G, Goudouneche D, Cambillau M, Kellner-Weibel G, Robinet P, Royer L, Moatti N, Simon A, Paul JL 2003 Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects. Atherosclerosis 171:287-293 (Pubitemid 37486081)
24. Nestel P, Hoang A, Sviridov D, Straznicky N 2012 Cholesterol efflux from macrophages is influenced differentially by plasmas from overweight insulin-sensitive and -resistant subjects. Int J Obes 36:407-413
25. Schaefer EJ, Brousseau ME, Diffenderfer MR, Cohn JS, Welty FK, O'Connor J, Dolnikowski GG, Wang J, Hegele RA, Jones PJ 2001 Cholesterol and apolipoprotein B metabolism in Tangier disease. Atherosclerosis 159:231-236 (Pubitemid 33016640)
26. Orsoni A, Villard EF, Bruckert E, Robillard P, Carrie A, Bonnefont-Rousselot D, Chapman MJ, Dallinga-Thie GM, Le Goff W, Guerin M 2012 Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia. J Lipid Res 53:767-775
27. Adorni MP, Zimetti F, Puntoni M, Bigazzi F, Sbrana F, Minichilli F, Bernini F, Ronda N, Favari E, Sampietro T 2012 Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDLapheresis. J Lipid Res 53:984-989
28. Rothblat GH, de la Llera-Moya M, Favari E, Yancey PG, Kellner-Weibel G 2002 Cellular cholesterol flux studies: methodological considerations. Atherosclerosis 163:1-8 (Pubitemid 34615720)
29. Kobori K, Saito K, Ito S, Kotani K, Manabe M, Kanno T 2002 A new enzyme-linked immunosorbent assay with two monoclonal antibodies to specific epitopes measures human lecithin-cholesterol acyltransferase. J Lipid Res 43:325-334 (Pubitemid 34184020)
30. Kiyohara T, Kiriyama R, Zamma S, Inazu A, Koizumi J, Mabuchi H, Chichibu K 1998 Enzyme immunoassay for cholesteryl ester transfer protein in human serum. Clin Chim Acta 271:109-118 (Pubitemid 28135210)
31. Watts GF, Karpe F 2011 Triglycerides and atherogenic dyslipidaemia: extending treatment beyond statins in the high-risk cardiovascular patient. Heart 97:350-356